What was the median EV/EBITDA multiple for Other Healthcare in 2026?

The median EV/EBITDA multiple for Other Healthcare acquisitions in 2026 was 11.19x, based on 10 disclosed transactions. The p25-p75 range was 6.67x to 33.8x.

What was the median EV/Revenue multiple for Other Healthcare in 2026?

The median EV/Revenue multiple for Other Healthcare acquisitions in 2026 was 1.18x, based on 16 disclosed transactions. The p25-p75 range was 0.75x to 6.33x.

2026M&A Transaction Multiples

Other Healthcare Multiples - 2026

Sourced from 17 publicly disclosed Other Healthcare acquisitions in 2026. Public records only (SEC EDGAR + verified press releases).

EV / EBITDA

11.2x

median · p25 6.7x - p75 33.8x · n=10

EV / Revenue

1.2x

median · p25 0.8x - p75 6.3x · n=16

Value your Other Healthcare business

Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.

Industry

Annual Revenue (USD)

EBITDA / SDE (USD)

Other Healthcare multiples by year

2026 · 11.19x EBITDA 2025 · 16x EBITDA 2024 · 13.77x EBITDA 2023 · 11.5x EBITDA 2022 · 13.4x EBITDA 2021 · 11.4x EBITDA 2020 · 11.1x EBITDA 2019 · 9.9x EBITDA 2018 · 10.1x EBITDA

Other verticals - 2026 multiples

Other· 15x EBITDA

Data sourced from 17 disclosed Other Healthcare M&A transactions in 2026. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →